À¶Ý®ÊÓƵ

QMS Webinar Series: System Level Test and Maturity Grid Risk Management

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

QMS Webinar Series: Failure Mode Effective Analysis

Speaker: Abdul Khalfan CQE, SSGB

Principal, Quality Assurance & Reliability Engineering Consulting Services

You are invited to the Graham Seed Fund Launch Event on Monday, October 31 at 12:00 p.m. ET, presented by Transformative Health Technologies.

Dr. Forster will describe the motivations for change in healthcare and describe how the Ottawa Hospital is supporting transformation using three related concepts: learning systems, data democratization, and open innovation.  At the foundation of these concepts is a need for strong leadership and trust to support the meaningful collaborations required to achieve meaningful impacts.

The (WAPPS-Hemo) is a clinical decision support tool aimed at using pharmacokinetics of prophylactic clotting factor replacement therapy as a means for individu

Abstract

The basic principles and experimental set-ups for Edge Illumination and Beam Tracking X-ray phase-contrast imaging (XPCI) are introduced, along with examples on key applications where phase-based imaging complements and advances the more conventional attenuation-based X-ray imaging. X-ray dark-field techniques are also discussed with an emphasis on the most recent developments on tomography and directional imaging.

The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “À¶Ý®ÊÓƵ for Health, Technology and Society

The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “À¶Ý®ÊÓƵ for Health, Technology and Society

Profs Present: Wearable sensors to inform mobility and health: Novel applications and advances in methodology

Abstract

DNA aptamers are single-stranded DNA oligonucleotides that can selectively bind to target molecules. They can be used for the detection of various metabolites and proteins as disease biomarkers. Our lab recently discovered new aptamers that can bind to caffeine, uric acid and lactate, and converted them to highly sensitive and selective fluorescent biosensors. In addition, we have isolated aptamers that can bind to exosomes, which could be used for the isolation and detection of exosomes as important disease biomarkers. Finally, we have isolated aptamers that can bind to pig cornea and established an aptamer-enhanced ocular drug delivery method to treat dry eye diseases.